Literature DB >> 7539285

Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors.

W J Van de Ven1, E F Schoenmakers, S Wanschura, B Kazmierczak, P F Kools, J M Geurts, S Bartnitzke, H Van den Berghe, J Bullerdiek.   

Abstract

Chromosome arm 12q breakpoints in seven cell lines derived from primary pleomorphic salivary gland adenomas were mapped by FISH analysis relative to nine DNA probes. These probes all reside in a 2.8 Mb genomic DNA region of chromosome segment 12q13-q15 and correspond to previously published sequence-tagged sites (STS). Their relative positions were established on the basis of YAC cloning and long range physical and STS content mapping. The 12q breakpoints of five of the cell lines were found to be mapping within three different subregions of the 445 kb DNA interval that was recently defined as the uterine leiomyoma cluster region of chromosome 12 breakpoints (ULCR12) between STS RM33 and RM98. All seven breakpoints appeared to map within the 1.7 Mb DNA region between STS RM36 and RM103. Furthermore, the chromosome 12 breakpoints of three primary pleomorphic salivary gland adenomas were also found to be mapping between RM36 and RM103. Finally, FISH analysis of two lipoma cell lines with 12q13-q15 aberrations pinpointed the breakpoints of these to relatively small and adjacent DNA segments which, as well as those of two primary lipomas, appeared to be located also between RM36 and RM103. We conclude from the observed clustering of the 12q breakpoints of the three distinct solid tumor types that the 1.7 Mb DNA region of the long arm of chromosome 12 between RM36 and RM103 is a multiple aberration region which we designate MAR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539285     DOI: 10.1002/gcc.2870120410

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors.

Authors:  P Rogalla; K Drechsler; G Frey; Y Hennig; B Helmke; U Bonk; J Bullerdiek
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

2.  Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.

Authors:  B J Quade; A P Pinto; D R Howard; W A Peters; C P Crum
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

3.  NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli.

Authors:  J Svaren; B R Sevetson; E D Apel; D B Zimonjic; N C Popescu; J Milbrandt
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  Cytogenic and molecular analysis of an aggressive angiomyxoma.

Authors:  B Kazmierczak; S Wanschura; K Meyer-Bolte; J Caselitz; P Meister; S Bartnitzke; W Van de Ven; J Bullerdiek
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

5.  A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family.

Authors:  B Staats; U Bonk; S Wanschura; P Hanisch; E F Schoenmakers; W J Van de Ven; S Bartnitzke; J Bullerdiek
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Correlated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental models.

Authors:  Markus Klemke; Marietta Henrike Müller; Werner Wosniok; Dominique Nadine Markowski; Rolf Nimzyk; Burkhard Maria Helmke; Jörn Bullerdiek
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.